🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Pharmacokinetic Modeling of Methadone

RecruitingNAAges 18 Years - 99 YearsAllUniversity Hospital, Montpellier
NCT05490732 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The management of patients with opioid addiction is a challenge insofar as many distractors or variability factors can interfere with the control of the addiction, whether they are psychological, psychiatric, environmental, pharmacokinetic or pharmacodynamic. Understanding this variability is potentially to be able to adjust a priori a dosage and to identify the factors of clinical response. Few population pharmacokinetic models exist for methadone and they generally concern the management of pain in palliative care patients or the management of opioid withdrawal syndrome in neonates. The hypothesis is therefore that the creation of such a model would make it possible to reduce patients' withdrawal periods, to set a target for plasma concentrations with a view to reducing dosages, and to empower the patient in his choice to monitor blood concentrations facilitated by a minimally invasive

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Major patients on methadone on the same dosage for at least 7 days. * Hospitalization for withdrawal in the addictology department of La Colombière or consultation within the unit for the treatment of drug addiction and dependence (Addictology Department). * 24 hours monitoring is possible and accepted Exclusion Criteria: * Patients that cannot be sampled because of weakened veins * Unable to received information about the study * Exclusion period determined by previous study * Adult protected by law or patient under guardianship * Not affiliated to french social security system * Not able to give written inform consent * Pregnant or breastfeeding woman * Underaged patients (under 18 years old) * Patient under court protection
💊

What it tests

  • Blood sampling
📍

Where

1 site
CHU de Montpellier
Montpellier, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy